Stay updated on Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Footer updates show a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:20:58.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Publication notes were updated: a new line clarifies that PubMed-sourced publications may or may not relate to the study, and a revision tag 'Revision: v3.3.2' was added. The older, longer description stating PubMed publications are automatically created by ClinicalTrials.gov and tied to the NCT number was removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:00:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The government funding status notice banner was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-18T07:00:28.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Minor UI/layout adjustments observed on the Study Details page; no changes to core content such as study purpose, eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:26.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.
    Difference
    3%
    Check dated 2025-10-06T05:37:06.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:07:40.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in Chinese HER2+ Breast Cancer Clinical Trial page.